Invented patented products, serving global customers
BioMedicure (Shanghai) Medical Research Co., Ltd. is authorized by BioMedicure, Inc. in the United States to use its patented technology and patented products "ATATES™" and "AMAMES™", immune clearance.Cancer cell populations and their derivatives and
the only company for mutated cell populations. Dr. Qian Yong is the patent inventor and CEO of the company. The new antigen patented products "ATATES™" and "AMAMES™" are customized by BioMedicure for high-end clients to continuously upgrade their immune systems, known as "Five Blessings" (longevity, wealth, health, good virtue, and a good end). The "Five Blessings" are 100% targeted at sub-health, diseases, or infections with one or multiple causes (multiple long-term cumulative effects), and 0% collateral damage to normal life systems/organs/tissues/cells (non-toxic side effects).
|
 |
| |
Upgrade the immune system, prevent and treat diseases
The new antigen products "ATATES™" and "AMAMES™" enable the client's immune system to continuously upgrade according to new antigens. The upgraded immune system synthesizes new antigen receptor T cells and polyclonal antibodies against new antigens in a short period, immune killing pathogens carrying new antigen products, including cancer cell populations and their derivatives, tumor cell populations, mutated cell populations, and infections (such as mycoplasma, viruses, bacteria, and fungi). The long-term immune memory of new antigens resides in B cells, which can prevent the recurrence of these causes. Because the diseased life systems are immune-killed, the normal life systems, including the movement system, digestive system, respiratory system, endocrine system, urinary system, reproductive system, nervous system, immune system, and circulatory system, are not harmed, so clients or patients with sub-health, diseases, or infections can fully recover their health. |
One-on-one patented products, one-on-one professional services
The new antigen products "ATATES™" and "AMAMES™" are used for customizing new antigen products. After the immune system of the sample provider is activated, the immune system removes self-antigens through its own lymph nodes, obtaining various new antigens, synthesizing new antigen receptor T cells,new antigen receptor plasma cells, and producing
polyclonal antibodies against new antigens and
new antigen receptor B cells
, enabling the immune system to upgrade according to various new antigens. Unlike drugs, new antigen products are exclusive to individuals because 1) they require samples of personal mutated cell populations or tumor cells or cancer cells and their derivatives or infections to customize new antigen products, and 2) the sample provider's immune system must be healthy (those who have not used chemotherapy drugs for a long time have healthy immune systems) to enable the upgrade. Therefore, new antigen products are one-on-one products (cannot be used by others) and require one-on-one services to achieve the greater goal of a win-win-win (client wins, doctor wins, and company wins). Clients and BioMedicure must closely cooperate, communicate, and collaborate to achieve the short-term and long-term immune clearance of cancer cell populations and their derivatives, tumor cell populations, mutated cell populations, and known and unknown infections with multiple new antigens, comprehensively immune-clear the diseased systems, and restore various abnormal indicators of all life systems in the body to normal ranges.
|
 |
Tel: 021-50815370
Fax: 021-50815370
E-mail: admin@biomedicure.com
Address: Building 2, Lane 720, Cai Lun Road, and Building 10, Lane 198, Zhang Heng Road, China (Shanghai) Pilot Free Trade Zone
Pay attention to WeChat public number
Payment Scan Code Registered Member
See more in-station information